Cargando…
Oral treatment for diabetes using α-glucosidase inhibitors was a risk factor for chronic obstructive pulmonary disease: a cohort study
Objectives: Currently, diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) have proven to be risk factors for each other. This study aimed to determine the risk relationship between COPD and five common oral medications for DM among patients with DM. Methods: This population-base...
Autores principales: | Wu, Sheng-Wen, Ho, Yung-Chyuan, Luo, Ci-Wen, Chen, Hung-Yi, Su, Chun-Hung, Kuan, Yu-Hsiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797545/ https://www.ncbi.nlm.nih.gov/pubmed/33437213 http://dx.doi.org/10.7150/ijms.55361 |
Ejemplares similares
-
α-Glucosidase Inhibitor Can Effectively Inhibit the Risk of Tuberculosis in Patients with Diabetes: A Nested Case-Control Study
por: Lin, Kai-Huang, et al.
Publicado: (2020) -
Influence of PM(2.5) Exposure Level on the Association between Alzheimer’s Disease and Allergic Rhinitis: A National Population-Based Cohort Study
por: Li, Ruo-Ling, et al.
Publicado: (2019) -
Heart valve operations associated with reduced risk of death from mitral valve disease but other operations associated with increased risk of death: a national population-based case–control study
por: Li, Ruo-Ling, et al.
Publicado: (2019) -
Synthesis and Evaluation of Coumarin-Chalcone Derivatives as α-Glucosidase Inhibitors
por: Hu, Chun-Mei, et al.
Publicado: (2022) -
QSAR Studies on Andrographolide Derivatives as α-Glucosidase Inhibitors
por: Xu, Jun, et al.
Publicado: (2010)